Lower estrogen redistributes fat from hips and thighs to the abdomen — the metabolically active visceral fat that drives cardiovascular and metabolic risk.
Hormonal changes impair glucose processing, making carbohydrate tolerance lower and weight management harder — even on the exact same diet.
Loss of muscle mass — accelerated by low testosterone and estrogen — directly reduces resting metabolic rate. Fewer calories burned at rest than at any prior point in your life.
An in-house precision scan — muscle mass, visceral fat, metabolic rate & segmental balance. The full picture, not just weight.
Built for perimenopause and menopause — hormonal context, body-composition data, and clinical oversight working together.
A comprehensive lab panel before any prescription — estrogen, testosterone, thyroid, insulin & cortisol.
InBody sets your true starting point — muscle, visceral fat & metabolic rate. We track against it at every follow-up.
A provider who understands GLP-1s, HRT & body composition together reviews your data and sets a realistic 90-day plan built around you.
Where most programs end, ours keeps going. Regular scans confirm fat loss, not muscle — and we adjust the dose on real data.
GLP-1s drop weight but don't rebuild muscle. Emsculpt NEO adds targeted muscle building & visceral-fat reduction — a layer no other valley clinic offers.
Learn More About Emsculpt NEOOnly name-brand, FDA-approved GLP-1s. Which one and what dose is a clinical decision — made after reviewing your labs, history & goals.
Prescribed only after a full medical evaluation. No compounded versions — FDA-approved branded products only. Insurance accepted for labs and, where eligible, the medications.